NSABP Members' Area
Password Protected - Access
Limited to NSABP Participating
Institutions Only
NSABP Foundation, Inc.
General NSABP Information
Financial Conflicts of
Interest Policy
Contact the NSABP
Employment
Clinical Trials Information
Clinical Trials Overview
Protocol Chart
Never Say Lost
Treatment Trials Information
Protocol B-51
Protocol B-52
Protocol B-53/S1207
Protocol B-55/BIG 6-13
Prevention Trials Information
Protocol P-1 - BCPT
Protocol P-2 - STAR
To report problems, ask
questions or make comments,
please send e-mail to:
Webmaster@nsabp.pitt.edu
Protocol B-10
A Protocol to Compare Combined Chemotherapy With and Without C. parvum + Hydrocortisone in The Management of Patients with Surgically Curable Breast Cancer
Specific Aims
The aim of this study is to test the following hypothesis:
C. parvum immunotherapy added to surgery and chemotherapy is more effective than surgery and chemotherapy alone; i.e., surgery with L-PAM + 5-FU + C. parvum + hydrocortisone (PF+CP) is more effective in prolonging disease-free survival and survival than surgery with L-PAM + 5-FU (PF).
